PMN Stock PMN is expected to report earnings to fall -564% to -20 cents per share on May 14

A.I.dvisor
at Tickeron.com
05/13/24
Loading...
PMN - ProMIS Neurosciences
ProMIS Neurosciences Earnings Graph
Q1'24
Est.
$-0.20
Q4'23
Beat
by $0.14
Q3'23
Beat
by $0.14
The last earnings report on December 31 showed earnings per share of -3 cents, beating the estimate of -17 cents. P/B Ratio (9.551) is normal, around the industry mean (10.609). P/E Ratio (0.000) is within average values for comparable stocks, (160.883). PMN's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.422). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (236.959). With 4.42K shares outstanding, the current market capitalization sits at 35.84M.
View a ticker or compare two or three
PMNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com